DISCOUNT ZERTIFIKAT - AMGEN | Real-time Bid/Ask 18:49:46 24/05/2024 BST | ||
| 181.51 EUR / 181.56 EUR | -0.34% |
|
| Current month | -0.19% | ||
| 1 month | +0.06% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24/05/24 | 181.5 | -0.35% |
| 23/05/24 | 182.2 | +0.31% |
| 22/05/24 | 181.6 | +0.44% |
| 21/05/24 | 180.8 | -0.21% |
| 20/05/24 | 181.2 | +0.07% |
Delayed Quote Börse Stuttgart
Last update May 24, 2024 at 04:17 pm
More quotesStatic data
| Product type | Discount Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Morgan Stanley |
| WKN | ME680K |
| ISIN | DE000ME680K9 |
| Date issued | 02/01/2024 |
| Maturity | 20/09/2024 (119 Days) |
| Parity | 1 : 1 |
| Emission price | 175.8 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 183 € |
|---|---|
| Lowest since issue | 173.1 € |
| Spread | 0.05 € |
| Spread % | 0.03% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
306.5
USD
Average target price
316.3
USD
Spread / Average Target
+3.19%
- Stock Market
- Certificates
- Certificat
